Literature DB >> 14685654

A waiver of consent for intensive care research?

François Lemaire1.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2003        PMID: 14685654     DOI: 10.1007/s00134-003-2063-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  13 in total

1.  Safeguarding patients in clinical trials with high mortality rates.

Authors:  B D Freeman; R L Danner; S M Banks; C Natanson
Journal:  Am J Respir Crit Care Med       Date:  2001-07-15       Impact factor: 21.405

2.  Implications of the EU directive on clinical trials for emergency medicine.

Authors:  Ernst A Singer; Marcus Müllner
Journal:  BMJ       Date:  2002-05-18

Review 3.  Ethical considerations for research in critically ill patients.

Authors:  Luca M Bigatello; Edward George; William E Hurford
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

4.  Research involving cognitively impaired adults.

Authors:  Jason H T Karlawish
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

5.  The therapeutic orientation to clinical trials.

Authors:  Franklin G Miller; Donald L Rosenstein
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

6.  How best to ventilate? Trial design and patient safety in studies of the acute respiratory distress syndrome.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

7.  A serious threat to evidence based resuscitation within the European Union.

Authors:  Fritz Sterz; Ernst A Singer; Bernd Böttiger; Douglas Chamberlain; Peter Baskett; Leo Bossaert; Petter Steen
Journal:  Resuscitation       Date:  2002-06       Impact factor: 5.262

8.  Are institutional review boards effective in safeguarding patients in intensive care units?

Authors:  F Lemaire; C Brun-Buisson
Journal:  Curr Opin Anaesthesiol       Date:  2000-04       Impact factor: 2.706

9.  Decision-making capacity and surrogate designation in French ICU patients.

Authors:  E Ferrand; A C Bachoud-Levi; M Rodrigues; S Maggiore; C Brun-Buisson; F Lemaire
Journal:  Intensive Care Med       Date:  2001-08       Impact factor: 17.440

10.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  6 in total

1.  To consent or not to consent, that is (not) the (sole) question. "And there is nothing new under the sun". Kohelet (also known as Ecclesiastes), 1:9. Bible.

Authors:  Didier Dreyfuss
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

2.  Further restrictions for ICU research.

Authors:  Pål Klepstad; Ola Dale
Journal:  Intensive Care Med       Date:  2005-11-10       Impact factor: 17.440

3.  Common sense won: engagement from experts repealed Norwegian restrictions for ICU research.

Authors:  Pål Klepstad; Anne Berit Guttormsen; Ola Dale
Journal:  Intensive Care Med       Date:  2007-06-29       Impact factor: 17.440

4.  Informed consent in clinical trials in critical care: experience from the PAC-Man Study.

Authors:  Sheila E Harvey; Diana Elbourne; Joanne Ashcroft; Carys M Jones; Kathryn Rowan
Journal:  Intensive Care Med       Date:  2006-09-21       Impact factor: 17.440

5.  Informed consent for research in ICU obtained before ICU admission.

Authors:  Catherine Chenaud; Paolo Merlani; Bara Ricou
Journal:  Intensive Care Med       Date:  2006-02-14       Impact factor: 17.440

Review 6.  Exceptions to the rule of informed consent for research with an intervention.

Authors:  Susanne Rebers; Neil K Aaronson; Flora E van Leeuwen; Marjanka K Schmidt
Journal:  BMC Med Ethics       Date:  2016-02-06       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.